Blog
RSS FeedPosted by Michael Wonder on 17 Jul 2019
Breast cancer patients to have further NICE approved drug combination option on Cancer Drugs Fund
17 July 2019 - Another potentially life-extending drug combination for some people with advanced breast cancer will now be available on ...
Posted by Michael Wonder on 16 Jul 2019
Caladrius Biosciences receives advanced therapy medicinal product classification for CLBS12, its CD34+ cell therapy for critical limb ischaemia
15 July 2019 - Caladrius Biosciences announced today that the EMA has granted Advanced Therapy Medicinal Product classification to the Company’s ...
Posted by Michael Wonder on 16 Jul 2019
Gilead and Novartis seek to expand what FDA considers as real-world data and real-world evidence
15 July 2019 - Just over two months ago, the US FDA released draft guidance explaining to drugmakers what constitutes ...
Posted by Michael Wonder on 16 Jul 2019
FDA accepts file and accelerates review of Novartis sickle cell disease medicine crizanlizumab
16 July 2019 - FDA grants crizanlizumab Priority Review based on Phase II data showing prevention of vaso-occlusive crises in patients ...
Posted by Michael Wonder on 16 Jul 2019
RFP - supply of rituximab
16 July 2019 - PHARMAC invites proposals for the supply of rituximab in New Zealand. ...
Posted by Michael Wonder on 16 Jul 2019
Irish cystic fibrosis family face €12,400 bill after deportation victory in Australia
15 July 2019 - An Irish family threatened with deportation from Australia because their son has cystic fibrosis have been ...
Posted by Michael Wonder on 15 Jul 2019
On prescription drug prices, will Trump turn words into action?
15 July 2019 - Last week, President Trump declared his administration would soon issue an executive order mandating a so-called ...
Posted by Michael Wonder on 15 Jul 2019
There is no single, best policy for drug prices
15 July 2019 - Most Americans would like the government to act, but a one-size-fits-all approach is unlikely to be the ...
Posted by Michael Wonder on 15 Jul 2019
FDA approves Bayer's Gadavist (gadobutrol) injection as the first and only contrast agent for use in cardiac magnetic resonance imaging in adult patients with known or suspected coronary artery disease
15 July 2019 - Coronary artery disease is an important public health issue-- a disease that affects 16.5 million Americans. ...
Posted by Michael Wonder on 15 Jul 2019
Implementation of “coverage with evidence development” drug approval strategies found lacking
15 July 2019 - Lessons from early deployments in The Netherlands. ...
Posted by Michael Wonder on 15 Jul 2019
The FDA disagrees with its own expert panels how often?
15 July 2019 - As the FDA grapples with rising pressure to approve new medicines more quickly, a new analysis ...
Posted by Michael Wonder on 15 Jul 2019
Teva announces FDA approval of AirDuo Digihaler (fluticasone propionate 113 mcg and salmeterol 14 mcg) inhalation powder
15 July 2019 - The first digital maintenance asthma inhaler therapy with integrated sensors joins Teva’s digital rescue inhaler therapy to ...
Posted by Michael Wonder on 15 Jul 2019
Private health care facing 'death spiral' if young, healthy users abandon insurance, report says
16 July 2019 - Australia's health care system has become increasingly unfair, costly and confusing, according to a new report, ...
Posted by Michael Wonder on 15 Jul 2019
Brexit: 'No guarantee' of medicines if no EU deal agreed
14 July 2019 - Scottish Brexit Secretary Mike Russell has said he cannot absolutely guarantee the supply of medicine to ...
Posted by Michael Wonder on 15 Jul 2019
Biden health care plan would curb drug prices, raise taxes on rich
15 July 2019 - Former U.S. Vice President Joe Biden, the front-runner in the Democratic presidential race, unveiled a health care ...
Posted by Michael Wonder on 15 Jul 2019
Are prescription drug prices going down?
15 July 2019 - On a key health-care issue, Trump and Gillibrand made opposite claims within days of each other. ...